Please wait a minute...

中国生物工程杂志

CHINA BIOTECHNOLOGY
中国生物工程杂志  2018, Vol. 38 Issue (5): 10-16    DOI: 10.13523/j.cb.20180502
研究报告     
骨形成蛋白9对人膀胱癌BIU-87细胞增殖和迁移的影响
苟理尧,刘梦瑶,夏菁,万群,孙恃雷,唐敏,张彦()
重庆医科大学检验医学院 临床检验诊断学教育部重点实验室 重庆 400016
The Effects of Bone Morphogenetic Protein 9(BMP9) on the Proliferation and Migration of Human Bladder Cancer BIU-87 Cells
Li-yao GOU,Meng-yao LIU,Jing XIA,Qun WAN,Chi-lei SUN,Min TANG,Yan ZHANG()
Key Laboratory of Diagnostic Medicine Designated by the Chinese Ministry of Education,Chongqing Medical University, Chongqing 400016, China
 全文: PDF(1393 KB)   HTML
摘要:

目的:人骨形成蛋白9(bone morphogenetic protein 9,BMP9)对人膀胱癌BIU-87细胞增殖和迁移的影响。方法:使用过表达BMP9基因的腺病毒(AdBMP9)感染BIU-87细胞,采用定量PCR检测BMP9 mRNA的表达,Western blot检测BMP9蛋白及BMP9下游相关信号通路蛋白的表达;MTT及集落形成实验检测BIU-87细胞增殖能力;划痕愈合实验及Transwell TM小室迁移实验检测BIU-87细胞迁移能力。结果:感染AdBMP9后,BIU-87细胞中BMP9的mRNA水平和蛋白质水平均显著增加;过表达BMP9后,BIU-87细胞的体外增殖和迁移能力明显增加;Western blot结果显示BMP9可明显激活AKT信号通路。结论:高表达BMP9可能通过激活AKT信号通路促进人膀胱癌BIU-87细胞的增殖和迁移。

关键词: 膀胱癌骨形成蛋白9(BMP9)BIU-87细胞细胞增殖细胞迁移    
Abstract:

Objective:To investigate the effects of bone morphogenetic protein 9 (BMP9) on the proliferation and migration of human bladder cancer BIU-87 cells.Methods:BIU-87 cells were infected with BMP9 recombinant adenovirus(AdBMP9); The mRNA levels of BMP9 were detected by Q-PCR; The BMP9 protein and its downstream associated signaling pathway protein levels were detected by Western blot; The MTT and colony formation assay were used to test the proliferation of BIU-87 cells; The wound healing and Transwell TM chamber assay were taken to evaluate the migration of BIU-87 cells. Results:The expression of BMP9 in BIU-87 cells was highly increased after AdBMP9 infection; Forced expression of BMP9 promotes both the proliferation and migration of BIU-87 cells; Western blot results showed that BMP9 overexpression also increased AKT phosphorylation.Conclusion:High levels of BMP9 may promote the proliferation and migration of bladder cancer BIU-87 cells by activating the AKT signaling pathway.

Key words: Bladder cancer    BMP9    BIU-87 cells    Cell proliferation    Cell migration
收稿日期: 2017-08-31 出版日期: 2018-06-05
ZTFLH:  Q78  
通讯作者: 张彦     E-mail: zy2753@hotmail.com
服务  
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章  
苟理尧
刘梦瑶
夏菁
万群
孙恃雷
唐敏
张彦

引用本文:

苟理尧,刘梦瑶,夏菁,万群,孙恃雷,唐敏,张彦. 骨形成蛋白9对人膀胱癌BIU-87细胞增殖和迁移的影响[J]. 中国生物工程杂志, 2018, 38(5): 10-16.

Li-yao GOU,Meng-yao LIU,Jing XIA,Qun WAN,Chi-lei SUN,Min TANG,Yan ZHANG. The Effects of Bone Morphogenetic Protein 9(BMP9) on the Proliferation and Migration of Human Bladder Cancer BIU-87 Cells. China Biotechnology, 2018, 38(5): 10-16.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.20180502        https://manu60.magtech.com.cn/biotech/CN/Y2018/V38/I5/10

图1  BMP9在正常膀胱黏膜与膀胱癌中的差异表达
图2  重组BIU-87细胞的构建
图3  BMP9促进膀胱癌BIU-87细胞的增殖
图4  BMP9促进膀胱癌BIU-87细胞的迁移
图5  BMP9激活BIU-87细胞的AKT信号通路
[1] Siegel R L, Miller K D, Jemal A . Cancer statistics, 2016. Ca A Cancer Journal for Clinicians, 2016,66(1):7.
doi: 10.3322/caac.21332
[2] 韩苏军, 张思维, 陈万青 , 等. 中国膀胱癌发病现状及流行趋势分析. 癌症进展, 2013,11(1):89-95.
Han S J, Zhang S W, Chen W Q , et al. Analysis of the status and trends of bladder cancer incidence in China. Oncology Progress, 2013,11(1):89-95.
[3] 韩苏军, 张思维, 陈万青 , 等. 中国膀胱癌死亡现状及流行趋势分析. 现代泌尿外科杂志, 2013,18(3):228-232.
Han S J, Zhang S W, Chen W Q , et al. Analysis of the status quo and trends: mortality in patients with bladder cancer in China, Journal of Modern Urology, 2013,18(3):228-232.
[4] Alarmo E L, Kallioniemi A . Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis. Endocrine-related Cancer, 2010,17(2):R123.
[5] Wang K, Feng H, Ren W , et al. BMP9 inhibits the proliferation and invasiveness of breast cancer cells MDA-MB-231. Journal of Cancer Research & Clinical Oncology, 2011,137(11):1687-1696.
doi: 10.1007/s00432-011-1047-4 pmid: 21892652
[6] Herrera B , García-álvaro M, Cruz S, et al. BMP9 is a proliferative and survival factor for human hepatocellular carcinoma cells. PLoS One, 2013,8(7):e69535.
doi: 10.1371/journal.pone.0069535 pmid: 3720667
[7] Kuzaka B, Janiak M, Włodarski K H , et al. Expression of bone morphogenetic protein-2 and -7 in urinary bladder cancer predicts time to tumor recurrence. Archives of Medical Science, 2015,11(2):378-384.
doi: 10.5114/aoms.2014.46796 pmid: 25995755
[8] Soloway M S . Editorial comment on: EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. European Urology, 2008,54(2):313.
doi: 10.1016/j.eururo.2008.04.052 pmid: 18468783
[9] van Rhijn B W, Burger M Y . Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. European Urology, 2009,56(3):430.
doi: 10.1016/j.eururo.2009.06.028 pmid: 19576682
[10] Yeung C, Dinh T, Lee J . The health economics of bladder cancer: an updated review of the published literature. Pharmacoeconomics, 2014,32(11):1093-1104.
doi: 10.1007/s40273-014-0194-2 pmid: 25056838
[11] Siegel R, Ma J, Zou Z , et al. Cancer statistics, 2014. Ca A Cancer Journal for Clinicians, 2014,64(1):9.
doi: 10.3322/caac.21208
[12] Xue M, Xu L I, Wenjing W U , et al. Upregulation of long non-coding RNA urothelial carcinoma associated 1 by CCAAT/enhancer binding protein α contributes to bladder cancer cell growth and reduced apoptosis. Oncology Reports, 2014,31(5):1993-2000.
doi: 10.3892/or.2014.3092 pmid: 4020618
[13] Jacobs B L, Lee C T, Montie J E . Bladder cancer in 2010: how far have we come. Ca A Cancer Journal for Clinicians, 2010,60(4):244-272.
doi: 10.3322/caac.20077 pmid: 20566675
[14] 葛仙伟, 黄后宝 . 膀胱癌相关分子生物学研究现状. 承德医学院学报, 2017,34(4):329-332.
Ge X W, Huang H B . Current status of molecular biology in bladder cancer. Journal of Chengde Medical College, 2017,34(4):329-332.
[15] Wu W, Zhang S, Li X , et al. Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One, 2013,8(9):e73920-e73920.
doi: 10.1371/journal.pone.0073920 pmid: 3771932
[16] Chen W, Luo K, Ke Z , et al. TBK1 promote bladder cancer cell proliferation and migration via Akt Signaling. Journal of Cancer, 2017,8(10):1892-1899.
doi: 10.7150/jca.17638 pmid: 5556653
[17] Chen Z . B7-H3 promotes the migration and invasion of human bladder cancer cells via the PI3K/Akt/STAT3 Signaling pathway. Journal of Cancer, 2017,8(5):816-824.
doi: 10.7150/jca.17759 pmid: 5381170
[18] 马明, 金国江, 付立业 . 上调microRNA-100对结肠癌HT-29细胞增殖和侵袭的影响. 现代肿瘤医学, 2016,24(7):1031-1033.
doi: 10.3969/j.issn.1672-4992.2016.07.003
Ma M, Jin G J, Fu L Y . The effect of up -regulating microRNA -100 in colon cancer HT -29 cells on prolifera-tion and apoptosis. Journal of Modern Oncology, 2016,24(7):1031-1033.
doi: 10.3969/j.issn.1672-4992.2016.07.003
[19] Xu C, Zeng Q, Xu W , et al. miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR. Molecular Cancer Therapeutics, 2013,12(2):207.
doi: 10.1158/1535-7163.MCT-12-0273
[20] Wang J, Zhang X, Wang L , et al. Downregulation of urinary cell-free microRNA-214 as a diagnostic and prognostic biomarker in bladder cancer. Journal of Surgical Oncology, 2015,111(8):992.
doi: 10.1002/jso.23937 pmid: 25975233
[21] Xing J Z, Hua Y, Cheng W Z , et al. Dysregulation of miR-15a and miR-214 in human pancreatic cancer. Journal of Hematology & Oncology, 2010,3(1):46.
doi: 10.1186/1756-8722-3-46 pmid: 21106054
[22] Tao C, Wu C, Hu H . AB266. Expression of long noncoding RNA lncRNA-n336928 is correlated with tumor stage and grade and overall survival in bladder cancer. Biochemical & Biophysical Research Communications, 2015,468(4):666-670.
doi: 10.21037/tau.2016.s266 pmid: 4842632
[23] Zhu H, Li X, Song Y , et al. Long non-coding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway. Biochem Biophys Res Commun, 2015,467(2):223-228.
doi: 10.1016/j.bbrc.2015.10.002 pmid: 26449463
[24] Wang Y, Chen W, Yang C , et al. Long non-coding RNA UCA1a(CUDR) promotes proliferation and tumorigenesis, of bladder cancer. International Journal of Oncology, 2012,41(1):276.
doi: 10.3892/ijo.2012.1443 pmid: 22576688
[25] Liang Z, Wang X, Xu X , et al. MicroRNA-608 inhibits proliferation of bladder cancer via AKT/FOXO3a signaling pathway. Molecular Cancer, 2017,16(1):96.
doi: 10.1186/s12943-017-0664-1 pmid: 28549468
[26] Li Y, Shan Z, Liu C , et al. MicroRNA-294 promotes cellular proliferation and motility through the PI3K/AKT and JAK/STAT pathways by upregulation of NRAS in bladder cancer. Biochemistry Biokhimiia, 2017,82(4):474.
doi: 10.1134/S0006297917040095 pmid: 28371605
[27] Wu W, Zhang S, Li X , et al. Ets-2 regulates cell apoptosis via the Akt pathway, through the regulation of urothelial cancer associated 1, a long non-coding RNA, in bladder cancer cells. PLoS One, 2013,8(9):e73920-e73920.
doi: 10.1371/journal.pone.0073920 pmid: 3771932
[1] 路玉祥,李元,方丹丹,王学博,杨万鹏,楚元奎,杨华. MiR-5047在乳腺癌细胞增殖迁移中的作用及表达调控*[J]. 中国生物工程杂志, 2021, 41(4): 9-17.
[2] 黄胜, 严启滔, 熊仕琳, 彭弈骐, 赵蕊. 基于CRISPR/Cas9-SAM系统CHD5基因过表达慢病毒载体的构建及对膀胱癌T24细胞增殖,迁移和侵袭能力的影响 *[J]. 中国生物工程杂志, 2020, 40(3): 1-8.
[3] 杨丹,田海山,李校堃. 成纤维细胞生长因子5的研究进展 *[J]. 中国生物工程杂志, 2020, 40(3): 117-124.
[4] 郝燕妮,李婷,范佳鑫,李罗,牛凌芳,欧俐苹,吴小候,罗春丽. shPLCε通过下调CDC25A抑制T24细胞的瓦伯格效应 *[J]. 中国生物工程杂志, 2018, 38(5): 33-39.
[5] 李依蔓,周钦. Herpud1对后肾间充质细胞的作用及其机制的探讨*[J]. 中国生物工程杂志, 2018, 38(3): 9-15.
[6] 冯源, 唐云, 徐蕾, 谭海刚. 海藻多糖通过下调肝癌细胞Hep3B糖酵解途径抑制细胞增殖和迁移[J]. 中国生物工程杂志, 2017, 37(9): 31-40.
[7] 赵燕, 郝燕妮, 刘南京, 李婷, 吴小候, 罗春丽. miR-145通过下调PLCε抑制膀胱癌EMT和迁移及其机制研究[J]. 中国生物工程杂志, 2017, 37(3): 27-36.
[8] 梁姗, 蒋子川, 冯均. 胭脂萝卜花青素提取及对NCI-N87细胞增殖侵袭的影响[J]. 中国生物工程杂志, 2017, 37(11): 101-108.
[9] 汤志雄, 苟德明. miRNA调控成肌分化的研究进展[J]. 中国生物工程杂志, 2017, 37(10): 103-110.
[10] 秦海霞, 崔红凯, 潘莹, 户瑞丽, 朱利红, 王世进. miR-335靶向Rho相关卷曲螺旋形成蛋白激酶1对卵巢癌细胞增殖的影响[J]. 中国生物工程杂志, 2016, 36(6): 24-31.
[11] 刘雪杰, 林巍然, 唐立春, 孙薇, 魏汉东, 姜颖. 慢病毒载体介导RAB27A基因过表达对人HepG2肝癌细胞增殖的影响[J]. 中国生物工程杂志, 2014, 34(9): 16-23.
[12] 陈丽, 曹莹. PKA对斑马鱼前肾发育的影响及其机制研究[J]. 中国生物工程杂志, 2014, 34(10): 41-48.
[13] 季辉, 王琦, 仲蕾, 魏文祥. URI基因稳定表达对肝癌SMMC-7721细胞增殖能力的影响[J]. 中国生物工程杂志, 2013, 33(6): 1-6.
[14] 吴琛, 田焕娜, 王媛媛, 刘芳铭, 张晓康, 李秦剑, 谢园园. GALNT14对人乳腺癌MCF-7细胞迁移的影响[J]. 中国生物工程杂志, 2012, 32(07): 8-15.
[15] 李晓娜, 宋关斌, 罗庆. 机械拉伸对骨髓间充质干细胞迁移行为的影响[J]. 中国生物工程杂志, 2012, 32(05): 1-6.